Metacrine Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Metacrine company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Metacrine Company Profile Get Rating Today - Breaking & Trending Today

Metacrine (NASDAQ:MTCR) Rating Lowered to Hold at Zacks Investment Research

Metacrine (NASDAQ:MTCR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Metacrine Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing therapies for patients with liver and gastrointestinal diseases. The company’s […] ....

United States , San Diego , Goldman Sachs Group Inc , Metacrine Company Profile Get Rating , Zacks Investment Research , Renaissance Technologies , America Corp , York Mellon Corp , Venture Management , Metacrine Inc , Get Rating , Sachs Group , New York Mellon Corp , Company Profile , Nasdaq Mtcr ,

Metacrine (NASDAQ:MTCR) Downgraded by Zacks Investment Research to "Hold"

Zacks Investment Research cut shares of Metacrine (NASDAQ:MTCR – Get Rating) from a buy rating to a hold rating in a research report report published on Thursday, Zacks.com reports. According to Zacks, “Metacrine Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing therapies for patients with liver and gastrointestinal diseases. The […] ....

United States , San Diego , Goldman Sachs Group Inc , Metacrine Company Profile Get Rating , Virtu Financial , Zacks Investment Research , Renaissance Technologies , York Mellon Corp , Venture Management , Metacrine Inc , Get Rating , New York Mellon Corp , Sachs Group , Company Profile , Nasdaq Mtcr ,

Metacrine, Inc. (NASDAQ:MTCR) Short Interest Update

Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 465,600 shares, a decrease of 20.9% from the February 13th total of 588,600 shares. Based on an average daily volume of 3,470,000 shares, the short-interest ratio is presently […] ....

Paul Edward Walker , Morgan Stanley , Securities Exchange Commission , Goldman Sachs Group Inc , Metacrine Company Profile Get Rating , Virtu Financial , Zacks Investment Research , Walleye Capital , Citadel Advisors , Metacrine Inc , Get Rating , Exchange Commission , Goldman Sachs Group , Sachs Group , Company Profile , Nasdaq Mtcr ,